Other healthcare facilities to follow soon, in light of “H. Res. 1216”, which proposes reduction of child-radiation dosing
“This disruptive EOS technology, invented by a Nobel Prize-winning physicist, is designed to dramatically reduce radiation doses for both children and adults while providing extremely accurate images for clinical diagnosis.”
Gordon D. Donald, III, MD, New Jersey Spine Group, LLC
ATLANTA & EATONTOWN, N.J. (Business Wire EON/PRWEB ) June 11, 2008 -- biospace med, an emerging medical technology company based in Atlanta, announced today that Eatontown, NJ-based New Jersey Spine Group, LLC, is the first healthcare facility in the United States to install the Company’s FDA-cleared ‘EOS’ x-ray imager—the world’s first ultra-low-dose x-ray technology. The first EOS installation at a U.S. healthcare facility comes on the heels of a resolution introduced earlier this month in the U.S. House of Representatives, “H. Res. 1216”, which proposes to reduce radiation dosages used in the imaging of children.
EOS can capture head-to-toe images of patients in a standing, weight-bearing position with a dramatic reduction in radiation dose—up to 10 times less than a conventional x-ray and up to 1000 times less than a CT (Computed Tomography) scan. Additionally, EOS images provide remarkable detail, enabling physicians to better diagnose and plan an effective course of treatment.
“EOS can be utilized for patients of all ages,” said Gordon D. Donald, III, MD, Managing Member and Director of Spinal Surgery for New Jersey Spine Group. “EOS is especially helpful in any situation where patients want to limit their exposure to radiation, and where long-length, weight-bearing images are needed. EOS truly represents breakthrough medical technology, and I believe every healthcare institution in the U.S. that currently images patients with a conventional digital x-ray will want to adopt this remarkable technology as soon as possible. Furthermore, because EOS uses considerably less radiation than a conventional x-ray or CT (Computed Tomography) scan, it is an extremely important advancement for children with pediatric scoliosis, a condition involving a curvature of the spine that usually requires repeated x-ray exams, perhaps as many as 20 to 25 radiological exams during the course of their clinical follow-up.”
“We are very pleased to announce the first U.S. installation of our ultra-low-dose EOS x-ray imager in one of the leading spine centers in the U.S.,” added Marie Meynadier, PhD, chief executive officer of biospace med. “EOS represents a whole new paradigm for the safe and effective imaging of patients, and we are looking forward to rolling out this revolutionary technology throughout the United States.”
About New Jersey Spine Group, LLC
New Jersey Spine Group, LLC, is located at 234 Industrial Way West, Eatontown, NJ 07724. Founded by Gordon D. Donald, III, MD, New Jersey Spine Group serves patients locally, nationally and internationally. Renowned spinal surgeons, pain management physicians, chiropractic physicians and physical therapists work collaboratively to provide patients with the finest spinal care. For further information, visit www.nj-spine.com.
About biospace med
biospace med was founded on a unique partnership between Nobel Prize-winning physicist Georges Charpak, PhD, and a team of biomedical engineers, orthopedic surgeons and radiologists who have developed a complete orthopedic imaging solution. The Company’s lead product, EOS ultra-low-dose 2D/3D x-ray imager, allows full-body imaging of patients in a weight-bearing position that enables global assessment of balance and posture. EOS is a total solution in orthopedic imaging now available in the U.S. since receiving FDA 510(k) clearance. The Company has corporate headquarters in Atlanta and Paris, an office in Montreal, and is targeting a $2 billion orthopedic imaging marketplace. The company is located at 120 Interstate North Parkway, Suite 116, Atlanta, GA 30339, (678)-564-5400. Learn more at www.biospacemed.com.